FDA Approves Topical Foam for Plaque Psoriasis of the Scalp and Body
Approval is for once-daily 0.3 percent roflumilast topical foam for patients 12 years and olderContinue Reading
Approval is for once-daily 0.3 percent roflumilast topical foam for patients 12 years and olderContinue Reading
FRIDAY, May 23, 2025 (HealthDay News) — Eczema sufferers could soon find it easier to track their skin condition, via a newly developed AI that can assess severity using uploaded smartphone images. The AI demonstrated high diagnostic accuracy in evaluating eczema shown in symptom photos uploaded by patients using theirContinue Reading
FRIDAY, May 9, 2025 (HealthDay News) — The U.S. Food and Drug Administration (FDA) is warning consumers and tattoo artists that two tattoo inks have tested positive for harmful bacteria and could lead to serious infections. The affected products are: Sacred Tattoo Ink, Raven Black (CI# 77266; Lot#: RB0624, BestContinue Reading
WEDNESDAY, April 30, 2025 (HealthDay News) — People with acne are at increased risk of developing an eating disorder, a new study says. Adult acne patients are 2.4 times more likely to have an eating disorder, researchers reported recently in the Journal of the European Academy of Dermatology and Venereology.Continue Reading
Zevaskyn is the first and only autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosaContinue Reading
THURSDAY, April 24, 2025 (HealthDay News) — A quick spray of medication might seem like an easy way to get thicker hair, but some folks say one sold online has left them battling sexual side effects, depression and even thoughts of suicide. Now, the U.S. Food and Drug Administration (FDA)Continue Reading
FRIDAY, April 18, 2025 (HealthDay News) — It’s taking too long for people with psoriatic arthritis to be diagnosed and treated, a new study argues. Visible signs of psoriatic arthritis appear months and even years before a person develops the full-blown inflammatory joint disease, British researchers reported in the AnnalsContinue Reading
WEDNESDAY, March 19, 2025 (HealthDay News) — Lower doses of a common antibiotic can curb hair loss caused by a rare skin condition, a new study says. The antibiotic doxycycline is commonly used to treat lymphocytic scarring alopecia, a condition in which the body’s immune cells target hair follicles, researchersContinue Reading
Agency says 90 percent of tested products have undetectable or extremely low levels of benzeneContinue Reading
MONDAY, March 10, 2025 (HealthDay News) — LED light therapy is touted by social media influencers as a trendy way to treat acne. And it actually appears to work, a new evidence review suggests. Both red and blue LED light therapy are safe and effective in clearing up mild toContinue Reading
© 2021 WeeklyMD.com - All Rights Reserved.